Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acetazolamide in Pulmonary Hypertension
NCT02755259Phase 3Completed
- Sponsor
- University of Zurich
- Start
- Jan 2017
- Primary completion
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of acetazolamide in pulmonary hypertension (PH), sponsored by University of Zurich. Started Jan 2017; status: completed.
02
Drugs
acetazolamide
03
Conditions
pulmonary hypertension (PH)
Beyond the preview
Go deeper on NCT02755259.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02755259.